Clinical Trials Directory

Trials / Conditions / Recurrent Kaposi Sarcoma

Recurrent Kaposi Sarcoma

8 registered clinical trials studyying Recurrent Kaposi Sarcoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingCollecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
NCT05663502
AIDS Malignancy Consortium—
Active Not RecruitingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced
NCT04514484
National Cancer Institute (NCI)Phase 1
CompletedNelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
NCT03077451
AIDS Malignancy ConsortiumPhase 2
WithdrawnGamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
NCT02137564
AIDS Malignancy ConsortiumPhase 2
CompletedLenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
NCT01057121
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedBortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
NCT01016730
National Cancer Institute (NCI)Phase 1
CompletedHalofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00064142
National Cancer Institute (NCI)Phase 2